Clearside Biomedical, Inc.

Track this case

Case overview

Case Number:

1:25-bk-12109

Court:

Delaware

Nature of Suit:

Firms

Companies

Sectors & Industries:

  1. December 19, 2025

    Biomedical Co. Gets Approval For Ch. 11 Auction In January

    Eye disease treatment developer Clearside Biomedical on Friday got permission from a Delaware bankruptcy judge for a January auction of its assets after saying it had resolved objections from shareholders and the U.S. Trustee's Office.

  2. December 02, 2025

    Catching Up With New Bankruptcy Case Action

    A solar energy business sought bankruptcy protection in Texas. The foreign representative of a consultancy founder's bankruptcy estate sought recognition of his Canadian insolvency proceedings. And a landlord in the Bronx entered Chapter 11.

  3. December 01, 2025

    Meet The Attorneys Leading Clearside Biomedical's Ch. 11

    A team of lawyers from Richards Layton & Finger PA and Cooley LLP is representing Clearside Biomedical, a company developing treatments for eye diseases, in a recently filed Chapter 11 case as it looks to sell its business. 

  4. November 25, 2025

    Catching Up With New Bankruptcy Case Action

    National home goods retailer American Signature Furniture filed for Chapter 11 after seeing a slump in sales compounded by macroeconomic conditions. A Canadian oil and natural gas driller asked for Chapter 15 recognition of its restructuring efforts. And two pharmaceutical developers filed for bankruptcy, with one looking to hold a Chapter 11 sale of its assets and the other eyeing a Chapter 7 liquidation.

  5. November 25, 2025

    Biomedical Co. Gets First-Day Ch. 11 Relief Amid Sale Push

    Clearside Biomedical Inc., a company that develops treatments for serious eye diseases, received a Delaware bankruptcy judge's permission Tuesday to pay contractors' wages and prepetition taxes as the company kicks off a Chapter 11 case designed to help find a buyer for its assets.

  6. November 24, 2025

    Ophthalmic Co. Hits Ch. 11 With $64M Debt, Eyeing Sale

    Clearside Biomedical, a company developing treatments for eye diseases, has filed for Chapter 11 protection in Delaware bankruptcy court with $64 million in debt, saying it will attempt to sell its business during the case.